Actively Recruiting
Prospective Evaluation of AI-ECG for SHD Detection
Led by Imperial College London · Updated on 2026-03-09
590
Participants Needed
5
Research Sites
90 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to improve the early detection of undiagnosed heart disease, which causes serious health issues, hospital admissions, and high healthcare costs. Researchers are exploring how artificial intelligence (AI) can analyse routine heart tests, called electrocardiograms (ECGs), to detect heart problems. These tests can be done using both traditional ECG machines and portable, wearable devices like smartwatches, making it easier for people to monitor their heart health at home. While AI has shown promise using past data, this study will involve the collection of ECG data and subsequent testing of its accuracy in real-world settings to ensure it works well for both doctors and patients. The goal is to see if AI can identify conditions like heart muscle weakness, valve issues, and high lung pressure from the ECG data of patients. The researchers will also compare AI's detections with other blood tests commonly used to diagnose heart disease. The AI models that will be used are being tested for research and validation purposes only. They will not be used for clinical decision-making or providing information to influence diagnosis, treatment, or patient care during the study. The AI outputs are not shared with clinicians and will have no impact on the care pathway. This research will demonstrate if AI-powered ECG analysis - whether from traditional or portable devices - can provide a low-cost, non-invasive way to detect heart disease early and improve health assessments.
CONDITIONS
Official Title
Prospective Evaluation of AI-ECG for SHD Detection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18-90 years
- No prior formal diagnosis of heart failure, pulmonary hypertension, or valvular heart disease
- Ability to provide informed consent
You will not qualify if you...
- Severe arrhythmia or unstable cardiovascular disease
- Prior formal diagnosis of heart failure, pulmonary hypertension, or valvular heart disease
- Presence of a cardiac implantable electronic device such as a permanent pacemaker or implantable cardioverter defibrillator
- Current or recent participation in any research studies prior to recruitment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Southmead Hospital
Bristol, United Kingdom
Actively Recruiting
2
Chelsea and Westminster Hospital
London, United Kingdom
Actively Recruiting
3
Hammersmith Hospital
London, United Kingdom
Actively Recruiting
4
St Mary's Hospital
London, United Kingdom
Actively Recruiting
5
West Middlesex University Hospital
London, United Kingdom
Actively Recruiting
Research Team
A
Ahmed YM El-Medany, MBChB, MRCP, MSc, FHEA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here